Autism Biomarker Consortium for Clinical Trials (ABC-CT)

What is the purpose of this trial?

Brief Summary:

This is a multicenter longitudinal study that aims to identify, develop and validate a set of measures that can be used as stratification biomarkers and/or sensitive and reliable objective measures of social impairment in autism spectrum disorders (ASD) that could serve as markers of long term clinical outcome. The main study will include 275 individuals: 200 ASD subjects between 6-11 years old, and 75 TD subjects roughly matched by age and sex to the ASD group.


Participation Guidelines

Ages: 6 - 11 years

Gender: Both


National Institute of Mental Health

Start Date: 09/21/2016

End Date: 11/30/2019

Last Updated: 10/11/2018

Study HIC#: 1701018759

Get Involved

For more information about this study, contact:
Nicole R Wright
+1 203-785-7539
n.wright@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

James McPartland

Principal Investigator

Sub-Investigators